Intelligence · Clinical Pipeline
R&D Pipeline Programs
ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.
- Programs indexed
- 20,548
- Companies
- 1,769
- Drugs tracked
- 4,797
Quick answer
NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.
-
COVID Convalescent Plasma
Xiyuan Hospital of China Academy of Chinese Medical Sciences
COVID-19
1 trial -
CT colonoscopy(normal dose)
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Polyps
1 trial -
CT three-dimensional reconstruction
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Rectal Cancer
1 trial -
Carbon Nanoparticle Suspension Injection
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Breast Cancer
1 trial -
Celebrex
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Knee Osteoarthritis
1 trial -
Celecoxib 400mg
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Peutz-Jeghers Syndrome
1 trial -
Chidamide
Xiyuan Hospital of China Academy of Chinese Medical Sciences
AML
1 trial -
Chinese herbal medicine
The First People's Hospital of Lianyungang
Acute on Chronic Liver Failure
1 trial -
Chinese herbs
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Depression
1 trial -
Ciprofol
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Sedation
1 trial -
Clarithromycin
Chinese University of Hong Kong
Bronchiectasis Adult
1 trial -
Clarithromycin
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Chronic Rhinosinusitis
1 trial -
Coenzyme Q10
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Cardiovascular Disease
1 trial -
Colchicine
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Transcatheter Aortic Valve Replacement
1 trial -
Compound Norethisterone Enanthate Injection
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Contraception Behavior
1 trial -
Computer Aided Diagnosis
Chinese University of Hong Kong
Upper Gastrointestinal Disorder
1 trial -
Conservative treatment
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Acute Pancreatitis
1 trial -
Conventional treatment
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Copd Exacerbation Acute
1 trial -
Cordyceps cicadae
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Visual Acuity
2 trials -
Coronary Computed Tomography Angiography
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Cardiovascular Primary Prevention Strategy
1 trial -
Coronary Computed Tomography Angiography
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Major Adverse Cardiovascular Events (MACE)
1 trial -
Coronary Computed Tomography Angiography
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Statin
1 trial -
Corticosteroid
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Heart Valve Diseases
1 trial -
Cow's milk
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Acute Respiratory Infection
1 trial
Frequently asked questions
What is the NovaPharmaNews pipeline directory?
It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.
Where does pipeline data come from?
Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.
How do I find pipeline programs by company or phase?
Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.
Data attribution and licensing: Data sources